CSL Limited (CMXHF)
OTCMKTS · Delayed Price · Currency is USD
118.50
+2.08 (1.79%)
Nov 24, 2025, 4:00 PM EST
CSL Limited Market Cap
CSL Limited has a market cap or net worth of $56.8 billion as of November 24, 2025. Its market cap has decreased by -37.38% in one year.
Market Cap
56.80B
Enterprise Value
68.04B
Revenue
15.56B
Ranking
n/a
PE Ratio
18.92
Stock Price
$118.50
Market Cap Chart
Since June 2, 1994, CSL Limited's market cap has increased from 230.16M to 56.80B, an increase of 24,579.46%. That is a compound annual growth rate of 19.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 24, 2025 | 57.05B | -32.38% |
| Dec 31, 2024 | 84.38B | -10.61% |
| Dec 29, 2023 | 94.40B | 0.09% |
| Dec 30, 2022 | 94.31B | -6.81% |
| Dec 31, 2021 | 101.20B | 1.81% |
| Dec 31, 2020 | 99.40B | 13.04% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 824.30M |
| Elite Pharmaceuticals | 555.46M |
| Glass House Brands | 520.88M |
| Tian'an Technology Group | 386.45M |
| CytoDyn | 384.62M |
| Northwest Biotherapeutics | 382.71M |
| American Oncology Network | 346.66M |
| Nika Pharmaceuticals | 311.89M |